In our previous study, we showed the activation of Smad 2, 3, and 4 via the TGFβ pathway in glioblastoma multiforme and primary glioma stem cells and discussed the importance of the smad pathway in brain diseases [35]. The gene discussed is TGFB1; the disease is central nervous system cancer.